DRKS00013357已完成4 期
Clinical Trial (according to §23b MPG) on performance, safety and clinical benefit of hysan Pflegespray, hysan Hyaluronspray and Ocean-Spray Plus in otorhinolaryngology. - RISICCA-2017
RSAPHARM Arzneimittel GmbH0 个研究点目标入组 240 人开始时间: 2017年11月22日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 0 Years 至 110 Years（—）
- 性别
- All
入选标准
- •Use of the nasal sprays in adults and children within the intended use
- •- indication for Treatment of dry nose symptoms
- •- at least three of the clinical symptoms have a value of mild, moderate, strong or very strong or at least two symptoms have a value of strong or very strong
- •- decision of the physician to recommend the use of a nasal spray has been made before the inclusion of the Patient in the Trial
- •- patients are enrolled only after they had been given sufficient Information and had provided written consent
排除标准
- •patients that do not fulfill the inclusion criteria
研究者
相似试验
已完成
不适用
Clinical Trial according to §23b MPG on Performance, safety and clinical benefit of hysan Nasensalbe (HYNASA-2018)J31.0J01Acute sinusitisChronic rhinitisDRKS00015670RSAPHARM Arzneimittel GmbH100
尚未招募
2 期
A clinical trial to evaluate the performance and safety of the wekebere system for monitoring fetal wellbeing during laborPregnancy and ChildbirthPACTR202311817720428Vilgro Africa120
进行中（未招募）
不适用
A Phase III, Randomized, Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on a Sulfonylurea in Combination With MetformiDiabetes Mellitus type 2MedDRA version: 12.1Level: LLTClassification code 10067585Term: Type 2 diabetes mellitusEUCTR2010-018318-62-HUMerck & Co., Inc.424
已完成
3 期
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant ChemotherapyBreast cancerJPRN-UMIN000021016RG Oncology1,636
已完成
2 期
Prevention of Anxiety and Depression in AdolescentCondition 1: Symptoms of anxiety. Condition 2: symptoms of Depression.Phobic anxiety disordersDepressive episodeIRCT201508274178N2Vice chancellor for research, Tehran University of Medical Sciences80